RB Capital Management LLC Takes Position in CME Group Inc. $CME

RB Capital Management LLC purchased a new stake in shares of CME Group Inc. (NASDAQ:CME) during the 2nd quarter, Holdings Channel reports. The fund purchased 2,703 shares of the financial services provider’s stock, valued at approximately $597,000.

Several other hedge funds have also recently bought and sold shares of CME. Whipplewood Advisors LLC boosted its position in CME Group by 2,075.0% during the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 83 shares during the period. Elkhorn Partners Limited Partnership acquired a new position in shares of CME Group in the 4th quarter valued at about $27,000. Hilton Head Capital Partners LLC acquired a new position in shares of CME Group in the 4th quarter valued at about $28,000. Mowery & Schoenfeld Wealth Management LLC purchased a new stake in shares of CME Group in the second quarter worth approximately $28,000. Finally, Legacy Wealth Managment LLC ID lifted its position in shares of CME Group by 191.9% in the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 71 shares in the last quarter. 87.75% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at CME Group

In other CME Group news, Director William R. Shepard acquired 325 shares of CME Group stock in a transaction that occurred on Thursday, June 25th. The stock was acquired at an average price of $230.57 per share, with a total value of $74,935.25. Following the purchase, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. This trade represents a 0.12% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 0.30% of the company’s stock.

CME Group Trading Up 1.7%

Shares of NASDAQ CME opened at $285.80 on Friday. The stock has a market cap of $102.77 billion, a price-to-earnings ratio of 24.24, a PEG ratio of 3.34 and a beta of 0.23. The business has a 50 day simple moving average of $253.80 and a 200 day simple moving average of $279.13. CME Group Inc. has a 52 week low of $218.31 and a 52 week high of $329.16. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02.

CME Group (NASDAQ:CME) last issued its quarterly earnings data on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.08. The firm had revenue of $1.71 billion for the quarter, compared to analyst estimates of $1.68 billion. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The company’s revenue for the quarter was up .8% on a year-over-year basis. During the same quarter last year, the firm earned $2.96 earnings per share. On average, research analysts predict that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, September 25th. Stockholders of record on Wednesday, September 9th will be issued a dividend of $1.30 per share. The ex-dividend date is Wednesday, September 9th. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.8%. CME Group’s dividend payout ratio (DPR) is currently 44.11%.

Wall Street Analyst Weigh In

Several research firms recently commented on CME. Keefe, Bruyette & Woods upgraded shares of CME Group from a “market perform” rating to an “outperform” rating and set a $305.00 price target for the company in a report on Thursday, June 18th. Deutsche Bank Aktiengesellschaft lowered shares of CME Group from a “buy” rating to a “hold” rating and dropped their price objective for the company from $286.00 to $270.00 in a research note on Wednesday, August 19th. UBS Group lowered their price target on shares of CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a report on Monday, July 6th. TD Cowen dropped their price target on shares of CME Group from $323.00 to $273.00 and set a “buy” rating on the stock in a research note on Monday, June 22nd. Finally, Wall Street Zen raised shares of CME Group from a “strong sell” rating to a “sell” rating in a research note on Saturday. Nine research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, CME Group has an average rating of “Hold” and an average target price of $288.56.

CME Group Company Profile

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.